Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease metabolic syndrome x
Comorbidity |type 2 diabetes
Sentences 72
PubMedID- 20586225 The consequence is a metabolic syndrome with type 2 diabetes and increased cardiovascular mortality.
PubMedID- 26221526 The aims of the present study were to evaluate whether carbohydrate intake is associated with quality of dietary protein and acid load, and whether these are related to metabolic syndrome in patients with type 2 diabetes.
PubMedID- 25760026 Insulin resistance is a common pathological state found in the metabolic syndromeassociated with obesity and type 2 diabetes mellitus, in which target tissues fail torespond properly to physiologic insulin levels (5,7).
PubMedID- 22650602 metabolic syndrome in type 2 diabetes: comparative prevalence according to two sets of diagnostic criteria in sub-saharan africans.
PubMedID- 22809366 In addition, fatty liver is a manifestation of metabolic syndrome, and is associated with obesity, type 2 diabetes mellitus (t2dm), and hypertriglyceridemia [11].
PubMedID- 22762010 Serum levels of c-peptide are associated with the metabolic syndrome in patients with type 2 diabetes and in diabetic patients with nephropathy and vascular disease [37].
PubMedID- 24816278 Hepatic manifestations of the metabolic syndrome (hmms) are associated with obesity, type 2 diabetes/insulin resistance, non-alcoholic fatty liver disease (nafld), and progression to non-alcoholic steatohepatitis (nash) [1].
PubMedID- 21936688 metabolic syndrome (mets) is associated with development of type 2 diabetes mellitus and increased risk for cardiovascular disease.
PubMedID- 21315688 Taken together, these results may provide evidence of the therapeutic potential of kr-66344, as a 11beta-hsd1 inhibitor, in obesity and type 2 diabetes patients with metabolic syndrome.
PubMedID- 20153706 Conclusions: the prevalence of metabolic syndrome in patients with type 2 diabetes in spain is high, even when the low consistency among who, ncep-atp iii and idf criteria is considered.
PubMedID- 24428913 However, in regards to omentin-1, few studies have evaluated the relationship between omentin-1 and the metabolic syndrome in patients without concomitant type 2 diabetes and/or cardiovascular disease (termed “nascent metabolic syndrome” by jialal et al.)
PubMedID- 24171882 Prevalence of metabolic syndrome in type 2 diabetes mellitus using ncep-atpiii, idf and who definition and its agreement in gwalior chambal region of central india.
PubMedID- 24462884 Background: alstrom syndrome is a recessively inherited condition characterised by severe insulin resistance and metabolic syndrome with progression to type 2 diabetes, hepatic dysfunction and coronary artery disease.
PubMedID- 25536005 Hypovitaminosis d in type 2 diabetes: relation with features of the metabolic syndrome and glycemic control.
PubMedID- 25657309 metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study.
PubMedID- 26097823 Prevalence of metabolic syndrome in type 2 diabetes mellitus patients.
PubMedID- 23115071 Introduction: at present, little data exists about the incidence of, and the risk factors associated with, metabolic syndrome (mets) in patients with type 2 diabetes mellitus (t2dm).
PubMedID- 20695946 Raised plasma urotensin ii in type 2 diabetes patients is associated with the metabolic syndrome phenotype.
PubMedID- 19479185 metabolic syndrome is independently associated with microalbuminuria in type 2 diabetes.
PubMedID- 24589612 Objective: to study the correlation between adipocytokines levels and metabolic syndrome (ms) in patients with newly diagnosed type 2 diabetes mellitus (t2dm).
PubMedID- 23707905 These results demonstrate that sglt2 selective inhibitor ipragliflozin improves not only hyperglycemia but also diabetes/obesity-associated metabolic abnormalities in type 2 diabetic mice and suggest that ipragliflozin may be useful in treating type 2 diabetes with metabolic syndrome.
PubMedID- 20012885 This study determines the prediction of low-risk lifestyle on type 2 diabetes in those with and without metabolic syndrome in a pooled sample of two representative finnish cohorts, collected in 1978-1980 and 2000-2001.

Page: 1 2